UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore various work from home opportunities that can help you earn extra cash. Take advantage of these options to boost your income.
22,767 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
United Wholesale Mortgage's parent raises its 2026 revenue forecast just before a key Two Harbors Investment vote on ...
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
Ray Dalio argues we are in stage five of the big cycle, signaling rising debt, widening inequality, and geopolitical ...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...
Investors on Wall Street are pouring capital into Ukraine's drone technology, led by Swarmers, signaling a new phase ...
Ready to dip a modest $100 into crypto? This guide breaks down two strong bets—Solana and Cardano—and shows how to ev...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
A fresh analysis places the calendar of tax season squarely in the economic spotlight, revealing a $146 billion burde...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...
The White House extended the deadline for Iran to reopen the Strait of Hormuz to April 6, sparking a fresh wave of oi...
Coinbase announced a restructuring that will cut roughly 700 positions, or 14% of its workforce, citing crypto market...